Reports
Reports
Sale
The blood processing devices and consumables market size was valued at USD 47.8 billion in 2023, driven by increasing infectious diseases among people and increasing FDA clearance for new solutions. The market size is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to achieve a value of USD 92.8 billion by 2032.
The market growth is expected to witness significant growth driven by technological advancements. For instance, recent advancements in blood collection technology by YourBio Health's TAP® Micro Select device receiving CE Marking have marked a significant step towards transforming blood processing. This remote, capillary whole blood collection technology not only streamlines the process but also holds promise in expediting the approval of vital treatments through enhanced efficiency in clinical trials. The approval of this innovative device has created new opportunities for broader applications in home-based testing, revolutionizing diagnostics, and wellness products.
This blood processing devices and consumables market growth is driven by the rising prevalence of infectious diseases and the growth of the geriatric population, which is more vulnerable to medical conditions requiring transfusions. The market is expected to be driven by the rising demand for blood transfusions and surgical interventions leading to significant growth in the market. As the incidence of infectious diseases increases, the need for safe and efficient blood processing equipment and supplies is also expected to increase, boosting the market growth. This includes products such as blood bags, filters, and centrifuges.
With an increase in the geriatric population, the risk of medical conditions from blood transfusions also increases. These conditions can include surgeries, chronic diseases, and cancer treatments. The increasing demand for the devices involved in blood transfusion and other procedures is a major factor driving the market growth. Healthcare facilities and blood banks are required to have the necessary equipment to process and store blood products to meet this growing demand. As a result, the growth of the market is expected to witness an upward trajectory in the forecast period.
Initiatives for Awareness to Aid the Blood Processing Devices and Consumables Market Demand
In August 2023, AABB published a new Guide to the Use of Blood Warming Devices, the Association’s latest publication designed to support members in their professional growth. This resource, developed by members of the AABB Transfusion Medicine Section Coordinating Committee, provides an overview of blood-warming technologies and highlights the advantages of the devices. It also provides information on indications for use, contraindications, warnings, and administrative aspects of the technologies.
Such comprehensive resources by respected authorities like AABB aim to educate healthcare professionals on the benefits, applications, and safety considerations of blood-warming technologies. This awareness may further enable healthcare professionals to increase adaptation of blood warming technologies, further aiding the blood processing devices and consumables market size.
Rising Research Activities to Bolster the Market Growth
In February 2023, a new blood product combining red blood cells and plasma in one bag was associated with better survival from a penetrating major trauma injury, a new study involving Queen Mary University of London has found. This innovation aligns with the growing demand for more efficient and effective blood products in emergency medical situations. Additionally, this breakthrough might encourage further research and development within the industry, fostering innovation in blood processing technologies to accommodate the production and utilization of these advanced blood products and further contribute to the blood processing devices and consumables market share.
FDA Approvals to Provide Significant Push to the Market
The market is further expected to be driven by several FDA approvals of the innovations in the market. For instance, Becton Dickinson's FDA clearance for the BD MiniDraw Collection System offers a less invasive way of obtaining blood samples, exhibiting a shift in traditional blood collection methods. This innovation is significantly expected to benefit various sectors which will enable convenient access to crucial lab tests for chronic conditions like hypertension and high cholesterol, further contributing the blood processing devices and consumables market share. The introduction of revolutionary devices enhances the methods for blood collection, advancing clinical trials, and the approval process for new treatments, fostering market growth. The combined impact of these technological advancements indicates an upward trajectory for market growth in the forecast period.
Market Breakup by Type
Market Breakup by End User
Market Breakup by Region
The United States is leading the market growth and is expected to keep leading the market in the forecast period as well. The dominance of the region can be attributed to the high focus on technological advancements and research and development. The market growth is also propelled by the presence of a well-established healthcare infrastructure consisting of state-of-the-art hospitals, diagnostic laboratories, and blood banks. The growth of the region can also be credited to the presence of prominent key players in the region.
In April 2023, Baxter International Inc. (NYSE: BAX), a US based leader in solutions to advance surgical innovation, revealed multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023. These innovations include the launch of the new Baxter Patient Warming system, the unveiling of the Helux Pro Connected Surgical Light, and the launch of Floseal + Recothrom flowable hemostat, all of which are on display in Baxter’s AORN booth #2027. This launch indicates a commitment to innovation and addressing unmet needs in the surgical field. Devices like these often use specific bioactive materials aiding the maintenance of patient normothermia. Such advancements often boost market growth by adapting technological innovation and meeting evolving healthcare demands.
In March 2023, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). The EAPP is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Blood Processing Devices and Consumables Market Overview
3.1 Global Blood Processing Devices and Consumables Market Historical Value (2017-2023)
3.2 Global Blood Processing Devices and Consumables Market Forecast Value (2024-2032)
4 Global Blood Processing Devices and Consumables Market Landscape
4.1 Global Blood Processing Devices and Consumables Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Blood Processing Devices and Consumables Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Blood Processing Devices and Consumables Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Blood Processing Devices and Consumables Market Segmentation
6.1 Global Blood Processing Devices and Consumables Market by Type
6.1.1 Market Overview
6.1.2 Blood Processing Devices
6.1.2.1 Blood Bank Freezers
6.1.2.2 Blood Grouping Analyzers
6.1.2.3 Blood Warmer
6.1.2.4 Blood Cell Processors
6.1.2.5 Other Blood Processing Devices
6.1.3 Blood Processing Consumables
6.1.3.1 Blood Bags
6.1.3.2 Blood Lancets
6.1.3.3 Vials
6.1.3.4 Blood Administration Sets
6.1.3.5 Others
6.2 Global Blood Processing Devices and Consumables Market by End User
6.2.1 Market Overview
6.2.2 Hospitals and Clinics
6.2.3 Diagnostic Laboratories
6.2.4 Other End Users
6.3 Global Blood Processing Devices and Consumables Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Blood Processing Devices and Consumables Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Blood Processing Devices and Consumables Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Blood Processing Devices and Consumables Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Blood Processing Devices and Consumables Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Blood Processing Devices and Consumables Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Roche Holdings AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Danaher Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Immucor, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Terumo Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Haemonetics Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Danaher Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Grifols International
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Thermo Fisher Scientific, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Teleflex Incorporated
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Thermogenesis Holdings, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Maco Pharma
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Biomerieux SA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Blood Processing Devices and Consumables Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 47.8 billion in 2023, driven by the rising infectious viruses.
The market is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 and is likely to reach a market value of USD 92.8 billion by 2032.
The increasing geriatric population and the increasing demand for blood processing equipment and supplies, the prevalence of infectious diseases, the rising demand for blood transfusions and surgical interventions, initiatives to raise awareness among healthcare providers are major factors driving the market growth.
The market growth is influenced by trends such as FDA approval of new and effective innovations, including FDA clearance for the BD MiniDraw Collection System.
The 7 major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Types of blood processing devices are blood bank freezers, blood grouping analyzers, blood warmers, blood cell processors, other blood processing devices. On the other hand, blood processing consumables include blood bags, blood lancets, vials, and blood administration sets, among others.
End users in the market are hospitals and clinics, diagnostic laboratories, other end users.
Key players involved in the market are Abbott Laboratories, Becton Dickinson and Company, Roche Holdings AG, Danaher Corporation, Immucor, Inc., Terumo Corporation, Haemonetics Corporation, Danaher Corporation, Grifols International, Thermo Fisher Scientific, Inc., Teleflex Incorporated, Thermogenesis Holdings, Inc., Maco Pharma, and Biomerieux SA.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.